[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:insulin":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Insulin",7,6,[8,15,22,28,34,41,47],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05899166","Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes",[],"RECRUITING","2026-08-26T02:18:25.327036Z","2026-05-05T02:43:29.192127Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07088068","A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes",[19],"Phase 3","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:28.185741Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06881992","A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism",[19],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.217045Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT05237934","Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.298667Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":39,"content_modified":40},"NCT06606327","Diazoxide Suppression Test P&F Study",[38],"Phase 1","2026-08-03T02:07:36.529363Z","2026-05-05T02:43:28.125552Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT07403604","Effect of Insulin Lowering on Lipogenesis",[38],"2026-08-26T02:17:22.949982Z","2026-05-05T02:43:29.663624Z",{"nct_id":48,"title":49,"phases":50,"status":51,"updated_at":52,"content_modified":53},"NCT06558422","Human Models of Selective Insulin Resistance: Pancreatic Clamp",[38],"NOT_YET_RECRUITING","2026-08-26T02:18:00.873391Z","2026-05-05T02:43:27.289604Z"]